Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $563.30 million. The enterprise value is $1.09 billion.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 160.03 million shares outstanding. The number of shares has increased by 2.17% in one year.
| Current Share Class | 160.03M |
| Shares Outstanding | 160.03M |
| Shares Change (YoY) | +2.17% |
| Shares Change (QoQ) | +0.77% |
| Owned by Insiders (%) | 1.76% |
| Owned by Institutions (%) | 83.89% |
| Float | 123.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.67 |
| PS Ratio | 1.47 |
| Forward PS | 1.29 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.55 |
| P/OCF Ratio | 4.54 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.19, with an EV/FCF ratio of 8.80.
| EV / Earnings | n/a |
| EV / Sales | 2.88 |
| EV / EBITDA | 11.19 |
| EV / EBIT | 11.43 |
| EV / FCF | 8.80 |
Financial Position
The company has a current ratio of 3.62
| Current Ratio | 3.62 |
| Quick Ratio | 3.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | 6.07 |
| Debt / FCF | 4.97 |
| Interest Coverage | 2.91 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 13.05% |
| Return on Capital (ROIC) | 16.59% |
| Revenue Per Employee | $1.42M |
| Profits Per Employee | -$9,225 |
| Employee Count | 267 |
| Asset Turnover | 0.83 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $74.68 million in taxes.
| Income Tax | 74.68M |
| Effective Tax Rate | 104.36% |
Stock Price Statistics
The stock price has decreased by -64.01% in the last 52 weeks. The beta is 0.47, so IRWD's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -64.01% |
| 50-Day Moving Average | 4.25 |
| 200-Day Moving Average | 6.79 |
| Relative Strength Index (RSI) | 35.53 |
| Average Volume (20 Days) | 1,474,113 |
Short Selling Information
The latest short interest is 10.96 million, so 6.85% of the outstanding shares have been sold short.
| Short Interest | 10.96M |
| Short Previous Month | 11.93M |
| Short % of Shares Out | 6.85% |
| Short % of Float | 8.84% |
| Short Ratio (days to cover) | 8.94 |
Income Statement
In the last 12 months, IRWD had revenue of $378.42 million and -$2.46 million in losses. Loss per share was -$0.02.
| Revenue | 378.42M |
| Gross Profit | 253.01M |
| Operating Income | 95.36M |
| Pretax Income | 88.16M |
| Net Income | -2.46M |
| EBITDA | 97.40M |
| EBIT | 95.36M |
| Loss Per Share | -$0.02 |
Full Income StatementBalance Sheet
The company has $88.21 million in cash and $614.87 million in debt, giving a net cash position of -$526.66 million or -$3.29 per share.
| Cash & Cash Equivalents | 88.21M |
| Total Debt | 614.87M |
| Net Cash | -526.66M |
| Net Cash Per Share | -$3.29 |
| Equity (Book Value) | -311.33M |
| Book Value Per Share | -1.95 |
| Working Capital | 129.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $124.17 million and capital expenditures -$353,000, giving a free cash flow of $123.82 million.
| Operating Cash Flow | 124.17M |
| Capital Expenditures | -353,000 |
| Free Cash Flow | 123.82M |
| FCF Per Share | $0.77 |
Full Cash Flow StatementMargins
Gross margin is 66.86%, with operating and profit margins of 25.20% and -0.65%.
| Gross Margin | 66.86% |
| Operating Margin | 25.20% |
| Pretax Margin | 18.91% |
| Profit Margin | -0.65% |
| EBITDA Margin | 25.74% |
| EBIT Margin | 25.20% |
| FCF Margin | 36.54% |
Dividends & Yields
IRWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.17% |
| Shareholder Yield | -2.17% |
| Earnings Yield | -0.44% |
| FCF Yield | 21.98% |
Dividend DetailsAnalyst Forecast
The average price target for IRWD is $12.00, which is 240.91% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.00 |
| Price Target Difference | 240.91% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 10.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRWD has an Altman Z-Score of -2.78 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.78 |
| Piotroski F-Score | 5 |